Company Haemonetics Corporation

Equities

HAE

US4050241003

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Haemonetics Corporation

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:02 2024-05-31 pm EDT			5-day change	1st Jan Change
84.08 ^USD	-0.67%		-4.82%	-1.67%

May. 29	Haemonetics Insider Sold Shares Worth $1,144,208, According to a Recent SEC Filing	MT
May. 29	Haemonetics Insider Sold Shares Worth $775,253, According to a Recent SEC Filing	MT

Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Companyâs Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment includes blood collection and processing devices and disposables for red cells, platelets and whole blood. The Companyâs Hospital segment consists of Interventional Technologies, which includes vascular closure devices and sensor-guided technologies, and Blood Management Technologies, which includes devices and methodologies for measuring coagulation characteristics of blood, and blood transfusion management software, among others.

Number of employees: 3,657

USD in Million	2023	Weight	2024	Weight	Delta
Plasma 43.2 %	500	42.8 %	565	43.2 %	+12.97%
Hospital 34.1 %	378	32.4 %	446	34.1 %	+17.92%
Blood Center 21.3 %	289	24.8 %	279	21.3 %	-3.60%
Service 1.7 %	21	1.8 %	22	1.7 %	+0.97%
Reconciling Items -0.2 %	-21	-1.8 %	-3	-0.2 %	-86.00%

USD in Million	2023	Weight	2024	Weight	Delta
United States 74.1 %	843	72.1 %	970	74.1 %	+15.08%
Europe 12.2 %	157	13.4 %	160	12.2 %	+2.21%
Asia 8.2 %	104	8.9 %	108	8.2 %	+3.27%
Japan 4.4 %	61	5.2 %	58	4.4 %	-5.23%
Other 1.0 %	4	0.3 %	13	1.0 %	+263.62%

Managers	Title	Age	Since
Christopher Simon CEO	Chief Executive Officer	60	16-05-15
James D'Arecca DFI	Director of Finance/CFO	53	22-04-10
Jan Hartmann CTO	Chief Tech/Sci/R&D Officer	-	06-07-31
Anila Lingamneni CTO	Chief Tech/Sci/R&D Officer	57	20-03-31
Olga Guyette IRC	Investor Relations Contact	-	16-01-31
Rajeev Varma PRN	Corporate Officer/Principal	-	18-07-31
Maryanne Farris AUD	Comptroller/Controller/Auditor	-	22-09-30
Josep Llorens PRN	Corporate Officer/Principal	62	18-07-31
David James Wilson PRN	Corporate Officer/Principal	-	17-09-17
Michelle Basil LAW	General Counsel	52	17-02-28

Members of the board	Title	Age	Since
Robert Abernathy BRD	Director/Board Member	69	17-10-17
Charles Dockendorff BRD	Director/Board Member	69	14-07-22
Ellen Zane CHM	Chairman	72	18-01-24
Michael Coyle BRD	Director/Board Member	62	20-04-15
Mark Kroll BRD	Director/Board Member	71	05-12-31
Claire Pomeroy BRD	Director/Board Member	69	19-04-23
Diane Bryant BRD	Director/Board Member	61	23-08-03
Christopher Simon CEO	Chief Executive Officer	60	16-05-15
Lloyd Johnson BRD	Director/Board Member	69	21-08-05

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	50,841,442	50,450,451 ( 99.23 %)	0	99.23 %

Name	Equities	%	Valuation
Capital Research & Management Co. (Global Investors) 13.14 %	6,674,751	13.14 %	585 M $
BlackRock Advisors LLC 11.16 %	5,668,163	11.16 %	497 M $
Vanguard Fiduciary Trust Co. 10.63 %	5,397,330	10.63 %	473 M $
Wellington Management Co. LLP 8.410 %	4,270,864	8.410 %	374 M $
LB Hercules Holdings LLC 7.459 %	3,788,123	7.459 %	332 M $
STATE STREET CORPORATION 3.608 %	1,832,170	3.608 %	161 M $
Fiduciary Trust Company International 2.744 %	1,393,643	2.744 %	122 M $
Royce & Associates LP 2.494 %	1,266,614	2.494 %	111 M $
T. Rowe Price Investment Management, Inc. 2.399 %	1,218,211	2.399 %	107 M $
Geode Capital Management LLC 2.216 %	1,125,416	2.216 %	99 M $

Haemonetics Corp.

125 Summer Street

02110, Boston

+781 848 7100

http://www.haemonetics.com

Name	Category and Sector
Haemonetics SA Haemonetics SA Packaged SoftwareTechnology Services Haemonetics SA designs, manufactures, markets and services blood processing systems. The company is headquartered in Signy, Switzerland.	Packaged Software
Haemonetics Manufacturing, Inc. Haemonetics Manufacturing, Inc. Medical SpecialtiesHealth Technology Part of Haemonetics Corp., Haemonetics Manufacturing, Inc. is a company that manufactures blood disposables sets and related medical devices. The company is based in Covina, CA.	Medical Specialties
Haemonetics International Finance SARL

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

84.08 USD

Average target price

113.5 USD

Spread / Average Target

+34.99%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
HAEMONETICS CORPORATION	-1.67%	4.27B
ABBOTT LABORATORIES	-7.16%	178B
MEDTRONIC PLC	-1.23%	107B
BECTON, DICKINSON AND COMPANY	-4.86%	67.04B
DEXCOM, INC.	-4.28%	47.23B
CENCORA, INC.	+10.32%	44.62B
HOYA CORPORATION	+9.65%	42.5B
TERUMO CORPORATION	+15.43%	25.22B
WEST PHARMACEUTICAL SERVICES, INC.	-5.88%	24.14B
ZIMMER BIOMET HOLDINGS, INC.	-5.38%	23.69B

Other Medical Equipment, Supplies & Distribution